Advocacy intelligence hub — real-time data for patient organizations
Xermelo: FDA approved
Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Xermelo
(telotristat etiprate)Orphan drugTerSera Therapeutics, LLC
12.1 Mechanism of Action Telotristat, the active metabolite of telotristat ethyl, is an inhibitor of tryptophan hydroxylase, which mediates the rate l...